menu ☰
menu ˟

[Department of Error] Department of Error

22 Mar 2014

Mullard A. FDA's rejection of alemtuzumab divides neurologists. Lancet 2014; 383: 859—In this World Report (March 8), Dennis Bourdette's surname was spelt incorrectly. This correction has been made to the online version as of March 21, 2014.

Date: 
22 March 2014

Click here to view the full article which appeared in The Lancet